Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 2
2022 3
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Recent advances in the treatment of tuberculosis.
Motta I, Boeree M, Chesov D, Dheda K, Günther G, Horsburgh CR Jr, Kherabi Y, Lange C, Lienhardt C, McIlleron HM, Paton NI, Stagg HR, Thwaites G, Udwadia Z, Van Crevel R, Velásquez GE, Wilkinson RJ, Guglielmetti L; Study group on Mycobacteria (ESGMYC) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). Motta I, et al. Clin Microbiol Infect. 2023 Jul 22:S1198-743X(23)00339-7. doi: 10.1016/j.cmi.2023.07.013. Online ahead of print. Clin Microbiol Infect. 2023. PMID: 37482332 Review.
Co-administration of treatment for rifampicin-resistant TB and chronic HCV infection: A TBnet and ESGMYC study.
Tunesi S, Dû DL, Gualano G, Millet JP, Skrahin A, Bothamley G, Casas X, Goletti D, Lange C, Musso M, Palmieri F, Pourcher V, Rioux C, Skrahina A, Veziris N, Viatushka D, Jachym-Fréchet M, Guglielmetti L; TBnet, The ESGMYC, and The French MDR-TB Group. Tunesi S, et al. J Infect. 2022 Jun;84(6):834-872. doi: 10.1016/j.jinf.2022.03.004. Epub 2022 Mar 7. J Infect. 2022. PMID: 35271917 No abstract available.
Rifapentine access in Europe: growing concerns over key tuberculosis treatment component.
Guglielmetti L, Günther G, Leu C, Cirillo D, Duarte R, Garcia-Basteiro AL, Goletti D, Jankovic M, Kuksa L, Maurer FP, Méchaï F, Tiberi S, van Leth F, Veziris N, Lange C; Study Group on Mycobacteria of the European Society of Microbiology and Infectious Diseases (ESGMYC), European Society of Mycobacteriology (ESM), European Respiratory Society (ERS) and; Tuberculosis Network European Trials group (TBnet). Guglielmetti L, et al. Eur Respir J. 2022 May 19;59(5):2200388. doi: 10.1183/13993003.00388-2022. Print 2022 May. Eur Respir J. 2022. PMID: 35589114 Free PMC article.
Country-specific approaches to latent tuberculosis screening targeting migrants in EU/EEA* countries: A survey of national experts, September 2019 to February 2020.
Margineanu I, Rustage K, Noori T, Zenner D, Greenaway C, Pareek M, Akkerman O, Hayward S, Friedland JS, Goletti D, Stienstra Y, Hargreaves S; ESGITM/ESGMYC Study Groups. Margineanu I, et al. Euro Surveill. 2022 Mar;27(12):2002070. doi: 10.2807/1560-7917.ES.2022.27.12.2002070. Euro Surveill. 2022. PMID: 35332865 Free PMC article.
What is the role of the EUCAST reference method for MIC testing of the Mycobacterium tuberculosis complex?
Schön T, Köser CU, Werngren J, Viveiros M, Georghiou S, Kahlmeter G, Giske C, Maurer F, Lina G, Turnidge J, van Ingen J, Jankovic M, Goletti D, Cirillo DM, Santin M, Cambau E; ESGMYC. Schön T, et al. Clin Microbiol Infect. 2020 Nov;26(11):1453-1455. doi: 10.1016/j.cmi.2020.07.037. Epub 2020 Aug 6. Clin Microbiol Infect. 2020. PMID: 32768492 Free article. No abstract available.
Initiation and completion of treatment for latent tuberculosis infection in migrants globally: a systematic review and meta-analysis.
Rustage K, Lobe J, Hayward SE, Kristensen KL, Margineanu I, Stienstra Y, Goletti D, Zenner D, Noori T, Pareek M, Greenaway C, Friedland JS, Nellums LB, Hargreaves S; ESGITM and ESGMYC study groups. Rustage K, et al. Lancet Infect Dis. 2021 Dec;21(12):1701-1712. doi: 10.1016/S1473-3099(21)00052-9. Epub 2021 Aug 4. Lancet Infect Dis. 2021. PMID: 34363771 Free PMC article.
Identification of Recent Tuberculosis Exposure Using QuantiFERON-TB Gold Plus, a Multicenter Study.
Pérez-Recio S, Pallarès N, Grijota-Camino MD, Sánchez-Montalvá A, Barcia L, Campos-Gutiérrez S, Pomar V, Rabuñal-Rey R, Balcells ME, Gazel D, Montiel N, Vicente D, Goić-Barišić I, Schön T, Paues J, Mareković I, Cacho-Calvo J, Barac A, Goletti D, García-Gasalla M, Barcala JM, Tórtola MT, Anibarro L, Suárez-Toste I, Moga E, Gude-Gonzalez MJ, Naves R, Karslıgil T, Martin-Peñaranda T, Stevanovic G, Trigo M, Rubio V, Karaoğlan İ, Bayram N, Alcaide F, Tebé C, Santin M; ESCMID Study Group for Mycobacterial Infections (ESGMYC) and the Mycobacteria Study Group (GEIM) of the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC). Pérez-Recio S, et al. Microbiol Spectr. 2021 Dec 22;9(3):e0097221. doi: 10.1128/Spectrum.00972-21. Epub 2021 Nov 10. Microbiol Spectr. 2021. PMID: 34756079 Free PMC article.